Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of t-cell clones from the donor

New England Journal of Medicine

Volumn 333, Issue 16, 1995, Pages 1038-1044

  Walter, Elizabeth A ^a   Greenberg, Philip D ^a   Gilbert, Mark J ^a   Finch, Rosalynde J ^a   Watanabe, Kåthe S ^a   Thomas, E Donnall ^a   Riddell, Stanley R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADOLESCENT; ADOPTIVE IMMUNOTHERAPY; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CELL TRANSFER; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DONOR; FEMALE; GENE REARRANGEMENT; HELPER CELL; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; RECIPIENT;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CLONE CELLS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMAN; IMMUNITY, CELLULAR; IMMUNOSUPPRESSION; IMMUNOTHERAPY, ADOPTIVE; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0028820386     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199510193331603     Document Type: Article

References (39)

1. Meyers JD, Flournoy N, Thomas ED Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153: 478-488
2. Forman SJ, Zaia JA Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? Blood 1994; 83: 2393-2398
3. Smith MA, Brennessel DJ Cytomegalovirus. Infect Dis Clin North Am 1994; 8: 427-438
4. Gallant JE, Moore RD, Richman DD Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992; 166: 1223-1227
5. Wiens M, Lefebre B, Blumhardt G, Schmidt CA, Lohmann R, Neuhaus P Incidence and therapy of cytomegalovirus disease after liver transplantation. Transplant Proc 1993; 25: 1985-1986
6. Farrugia E, Schwab TR Management and prevention of cytomegalovirus infection after renal transplantation. Mayo Clin Proc 1992; 67: 879-890
7. Bowden RA, Sayers M, Flournoy N, Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986; 314: 1006-1010
8. Miller WJ, McCullough J, Balfour HH Jr, Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening. Bone Marrow Transplant 1991; 7: 227-234
9. Zaia JA. Cytomegalovirus infection. In: Forman SJ, Blume KG, Thomas ED, eds. Bone marrow transplantation. Cambridge, Mass.: Blackwell Science, 1994:376-403.
10. Bowden RA, Slichter SJ, Sayers MH, Mori M, Cays MJ, Meyers JD Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood 1991; 78: 246-250
11. Goodrich JM, Mori M, Gleaves CA, Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 1991; 325: 1601-1607
12. Schmidt GM, Horak DA, Niland JC, A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 1991; 324: 1005-1011
13. Reed EC, Bowden RA, Dandliker PS, Lilleby KE, Meyers JD Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 1988; 109: 783-788
14. Emanuel D, Cunningham I, Jules-Elysee K, Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 1988; 109: 777-782
15. Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 1993; 118: 173-178
16. Boeckh M, Gooley T, Goodrich J, Sullivan K, Bowden RA. Increased incidence of late cytomegalovirus disease in patients who received ganciclovir prophylaxis after allogeneic marrow transplantation. In: Abstracts of the Eighth International Symposium on Infections in the Immunocompromised Host, Davos, Switzerland, June 19– 22, 1994. Comstock, Mich.: Immunocompromised Host Society, 1994. abstract.
17. Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994; 83: 1971-1979
18. Quinnan GV Jr, Kirmani N, Rook AH, Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med 1982; 307: 7-13
19. Reusser P, Riddell SR, Meyers JD, Greenberg PD Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991; 78: 1373-1380
20. Reddehase MJ, Mutter W, Munch K, Buhring HJ, Koszinowski UH CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 1987; 61: 3102-3108
21. Reddehase MJ, Weiland F, Munch K, Jonjic S, Luske A, Koszinowski UH Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 1985; 55: 264-273
22. Papadopoulos ED, Ladanyi M, Emanuel D, Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994; 330: 1185-1191
23. Rooney CM, Smith CA, Ng CY, Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995; 345: 9-13
24. Riddell SR, Rabin M, Geballe AP, Britt WJ, Greenberg PD Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. J Immunol 1991; 146: 2795-2804
25. McLaughlin-Taylor E, Pande H, Forman SJ, Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol 1994; 43: 103-110
26. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992; 257: 238-241
27. Riddell SR, Greenberg PD The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J Immunol Methods 1990; 128: 189-201
28. Laubscher A, Bluestein HG, Spector SA, Zvaifler NJ Generation of human cytomegalovirus-specific cytotoxic T-lymphocytes in a short-term culture. J Immunol Methods 1988; 110: 69-77
29. Thomas ED, Storb R, Clift RA, Bone-marrow transplantation. N Engl J Med 1975; 292: 832-843
30. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory, 1989.
31. Genev'ee C, Diu A, Nierat J, An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 1992; 22: 1261-1269
32. Casanova JL, Romero P, Widmann C, Kourilsky P, Maryanski JL T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire. J Exp Med 1991; 174: 1371-1383
33. Malissen M, Trucy J, Letourneur R, A T cell clone expresses two T cell receptor alpha genes but uses one alpha beta heterodimer for allorecognition and self MHC-restricted antigen recognition. Cell 1988; 55: 49-59
34. Padovan E, Casorati G, Dellabona P, Meyer S, Brockhaus M, Lanzavecchia A Expression of T cell receptor alpha chains: dual receptor T cells. Science 1993; 262: 422-424
35. Sanger F, Nicklen S, Coulson AR DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977; 74: 5463-5467
36. Matloubian M, Concepcion RJ, Ahmed R CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 1994; 68: 8056-8063
37. Alford CA, Stagno S, Pass RF. Natural history of perinatal cytomegaloviral infection. In: Elliot K, ed. Perinatal infections. Amsterdam: Excerpta Medica, 1980:125-47.
38. Porter DL, Roth MS, McGarigle C, Ferrara JLM, Antin JH Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 1994; 330: 100-106
39. Reddehase MJ, Mutter W, Koszinowski UH In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection. J Exp Med 1987; 165: 650-656